Inhibition of NLRP3 with therapies like MCC950 and PHLDA1 (pleckstrin homology-like domain family A member 1) also improved intestinal inflammation and survival in experimental NEC (82, 85). The gene discussed is PHLDA1; the disease is necrotizing enterocolitis.